Wells Fargo & Company Immunity Bio, Inc. Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 270,245 shares of IBRX stock, worth $562,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares

270,245

Previous 273,113 1.05%

Holding current value

$562,109

Previous $721,000 7.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$2.24 - $3.01 $6,424 - $8,632	-2,868 Reduced 1.05%	270,245 $664,000
Q2 2025 Aug 14, 2025	BUY	$1.89 - $3.44 $201,026 - $365,888	106,363 Added 63.79%	273,113 $721,000
Q1 2025 May 13, 2025	BUY	$2.32 - $3.9 $65,296 - $109,765	28,145 Added 20.31%	166,750 $501,000
Q4 2024 Feb 12, 2025	BUY	$2.56 - $6.17 $82,775 - $199,500	32,334 Added 30.43%	138,605 $354,000
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $12,602 - $25,433	3,796 Added 3.7%	106,271 $394,000

Q2 2024 Aug 13, 2024	BUY	$4.82 - $9.15 $235,167 - $446,428	48,790 Added 90.88%	102,475 $647,000
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $7,535 - $14,394	2,333 Added 4.54%	53,685 $288,000
Q4 2023 Feb 09, 2024	BUY	$1.25 - $5.21 $14,747 - $61,467	11,798 Added 29.83%	51,352 $257,000
Q3 2023 Nov 13, 2023	SELL	$1.29 - $3.1 $31,474 - $75,636	-24,399 Reduced 38.15%	39,554 $66,000
Q2 2023 Aug 15, 2023	BUY	$1.53 - $6.41 $47,200 - $197,748	30,850 Added 93.19%	63,953 $177,000
Q1 2023 May 12, 2023	BUY	$1.35 - $4.78 $25,312 - $89,625	18,750 Added 130.63%	33,103 $60,000
Q4 2022 Feb 13, 2023	SELL	$4.35 - $6.77 $18,909 - $29,429	-4,347 Reduced 23.25%	14,353 $72,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $8,989 - $15,837	2,463 Added 15.17%	18,700 $93,000
Q2 2022 Aug 12, 2022	SELL	$2.68 - $6.14 $313,675 - $718,644	-117,043 Reduced 87.82%	16,237 $61,000
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $48,702 - $72,619	9,644 Added 7.8%	133,280 $748,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $8,907 - $15,992	-1,571 Reduced 1.25%	123,636 $752,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $331,587 - $514,918	-36,160 Reduced 22.41%	125,207 $1.22 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $1.47 Million - $2.46 Million	109,900 Added 213.53%	161,367 $2.3 Million
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $660,321 - $2.17 Million	51,467 New	51,467 $1.22 Million

Others Institutions Holding IBRX

# of Institutions

298

Shares Held

137M

Call Options Held

2.59M

Put Options Held

3.35M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $833M
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Immunity Bio, Inc. Transaction History